skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Topical calcineurin inhibitors in systemic lupus erythematosus

Review

(1954) Views  (742) Full article downloads

Authors: Christos E Lampropoulos, David P D’Cruz

Published Date April 2010 Volume 2010:6 Pages 95 - 101
DOI: http://dx.doi.org/10.2147/TCRM.S3193

Christos E Lampropoulos, David P D’Cruz

Lupus Research Unit, Rayne Institute, St. Thomas’ Hospital, London, UK

Abstract: Cutaneous lupus erythematosus (CLE) encompasses a variety of lesions that may be refractory to systemic or topical agents. Discoid lupus erythematosus (DLE) and subacute cutaneous lupus erythematosus (SCLE) are the most common lesions in clinical practice. The topical calcineurin inhibitors, tacrolimus and pimecrolimus, have been used to treat resistant cutaneous lupus since 2002 and inhibit the proliferation and activation of T-cells and suppress immune-mediated cutaneous inflammation. This article reviews the mechanism of action, efficacy, adverse effects, and the recent concern about their possible carcinogenic effect. Although the total number of patients is small and there is only one relevant randomized controlled study, the data are encouraging. Many patients, previously resistant to systemic agents or topical steroids, improved after four weeks of treatment. DLE and SCLE lesions were less responsive, reflecting the chronicity of the lesions, although more than 50% of patients still showed improvement. Topical calcineurin inhibitors may be a safe and effective alternative to topical steroids for CLE although the only approved indication is for atopic dermatitis.

Keywords: tacrolimus, pimecrolimus, cutaneous lupus erythematosus, topical calcineurin inhibitors








Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
Ropinirole in restless legs syndrome and periodic limb movement disorder
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Erratum
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Alopecia: evaluation and treatment
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy